104 related articles for article (PubMed ID: 1697966)
1. Analysis of somatic cell hybrids derived from normal human prostatic epithelial cells fused with HeLa cells.
Peehl DM; Wong ST; McNeal JE; Stamey TA
Prostate; 1990; 17(2):123-36. PubMed ID: 1697966
[TBL] [Abstract][Full Text] [Related]
2. Characterization of human keratinocyte X HeLa somatic cell hybrids.
Peehl DM; Stanbridge EJ
Int J Cancer; 1981 May; 27(5):625-35. PubMed ID: 6169665
[TBL] [Abstract][Full Text] [Related]
3. Identification of a human chromosome 11 gene which is differentially regulated in tumorigenic and nontumorigenic somatic cell hybrids of HeLa cells.
Lichy JH; Modi WS; Seuanez HN; Howley PM
Cell Growth Differ; 1992 Aug; 3(8):541-8. PubMed ID: 1390339
[TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenicity in somatic cell hybrids. II. Human chromosomes implicated as suppressors of tumorigenicity in hybrids with Chinese hamster ovary cells.
Klinger HP; Shows TB
J Natl Cancer Inst; 1983 Sep; 71(3):559-69. PubMed ID: 6577230
[TBL] [Abstract][Full Text] [Related]
5. Effect of retroviral integration on control of expression of a tumor marker in HeLa cells.
Gross MM; Janiaud P; Stanbridge EJ
Mol Carcinog; 1993; 8(2):89-95. PubMed ID: 7691070
[TBL] [Abstract][Full Text] [Related]
6. Induced terminal differentiation and tumorigenic suppression in murine keratinocyte somatic-cell hybrids.
Schneider BL; Kulesz-Martin M; Bowden GT
Mol Carcinog; 1995 May; 13(1):6-14. PubMed ID: 7766311
[TBL] [Abstract][Full Text] [Related]
7. Stable nontumorigenic phenotype of somatic cell hybrids between malignant Burkitt's lymphoma cells and autologous EBV-immortalized B cells despite induction of chromosomal breakage and loss.
Jox A; Taquia E; Vockerodt M; Draube A; Pawlita M; Möller P; Bullerdiek J; Diehl V; Wolf J
Cancer Res; 1998 Nov; 58(21):4930-9. PubMed ID: 9810002
[TBL] [Abstract][Full Text] [Related]
8. Suppression of tumorigenicity in somatic cell hybrids. IV. Chromosomes of normal human cells associated with suppression of tumorigenicity in hybrids with D98AH2 carcinoma cells.
Klinger HP; Kaelbling M
Cytogenet Cell Genet; 1986; 42(4):225-35. PubMed ID: 3463446
[TBL] [Abstract][Full Text] [Related]
9. Tumorigenicity of human HT1080 fibrosarcoma X normal fibroblast hybrids: chromosome dosage dependency.
Benedict WF; Weissman BE; Mark C; Stanbridge EJ
Cancer Res; 1984 Aug; 44(8):3471-9. PubMed ID: 6744274
[TBL] [Abstract][Full Text] [Related]
10. Suppression of tumorigenicity in somatic cell hybrids. III. Cosegregation of human chromosome 11 of a normal cell and suppression of tumorigenicity in intraspecies hybrids of normal diploid x malignant cells.
Kaelbling M; Klinger HP
Cytogenet Cell Genet; 1986; 41(2):65-70. PubMed ID: 3956263
[TBL] [Abstract][Full Text] [Related]
11. Analysis of oncogene, tumor suppressor gene, and chromosomal alterations in HeLa x osteosarcoma somatic cell hybrids.
Isfort RJ; Cody DB; Lovell GJ; Gioeli D; Weissman BE; Doersen CJ
Mol Carcinog; 1999 May; 25(1):30-41. PubMed ID: 10331742
[TBL] [Abstract][Full Text] [Related]
12. Characterization of intestinal alkaline phosphatase expression and the tumorigenic potential of gamma-irradiated HeLa x fibroblast cell hybrids.
Mendonca MS; Antoniono RJ; Latham KM; Stanbridge EJ; Redpath JL
Cancer Res; 1991 Aug; 51(16):4455-62. PubMed ID: 1868467
[TBL] [Abstract][Full Text] [Related]
13. Suppression of tumorigenicity of a human lung carcinoma line by nontumorigenic bronchial epithelial cells in somatic cell hybrids.
Kaighn ME; Gabrielson EW; Iman DS; Pauls EA; Harris CC
Cancer Res; 1990 Mar; 50(6):1890-6. PubMed ID: 2306741
[TBL] [Abstract][Full Text] [Related]
14. Localization of HeLa cell tumor-suppressor gene to the long arm of chromosome II.
Misra BC; Srivatsan ES
Am J Hum Genet; 1989 Oct; 45(4):565-77. PubMed ID: 2577469
[TBL] [Abstract][Full Text] [Related]
15. Evidence for suppression of cellular growth in vitro and selection against the indigenous mouse X chromosome in A9 cell hybrids after microcell-mediated transfer of an X from other mammalian species.
Islam MQ; Islam K
Cytogenet Cell Genet; 2000; 88(1-2):110-3. PubMed ID: 10773682
[TBL] [Abstract][Full Text] [Related]
16. Examination of the oncogenic potential of a tumor-associated antigen, intestinal alkaline phosphatase, in HeLa x fibroblast cell hybrids.
Latham KM; Stanbridge EJ
Cancer Res; 1992 Feb; 52(3):616-22. PubMed ID: 1732049
[TBL] [Abstract][Full Text] [Related]
17. The role of differentiation in the suppression of tumorigenicity in human cell hybrids.
Peehl DM; Stanbridge EJ
Int J Cancer; 1982 Jul; 30(1):113-20. PubMed ID: 7118295
[TBL] [Abstract][Full Text] [Related]
18. The ability of normal mouse cells to reduce the malignant potential of transformed mouse bladder epithelial cells depends on their somatic origin.
Cowell JK; Franks LM
Int J Cancer; 1984 May; 33(5):657-67. PubMed ID: 6724740
[TBL] [Abstract][Full Text] [Related]
19. Suppressor genes for malignant and anchorage-independent phenotypes located on human chromosome 9 have no dosage effects.
Islam MQ; Islam K
Cytogenet Cell Genet; 2000; 88(1-2):103-9. PubMed ID: 10773681
[TBL] [Abstract][Full Text] [Related]
20. Genetic analysis of an in vitro model system for human papillomavirus type 16-associated tumorigenesis.
Seagon S; Dürst M
Cancer Res; 1994 Nov; 54(21):5593-8. PubMed ID: 7923202
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
